Creative Drug Industries appreciates that the allergologist needs high quality, reliability and predictability from the allergens meant for patients who depend on him. There can be no compromise in the patient’s care, and we understand the crucial role of our products and services in the system.
Highlights of the allergen technology adopted by CDI in the manufacture of diagnostic and therapeutic allergens are:
Standardization is done on PNU (Protein Nitrogen Units) basis / Biological Potency.
Allergen extracts are di-filtered to remove non-allergenic substances.
Terminal sterility testing is done on each and every batch besides bulk sterility test.
Skin Test Allergens are based on Prick Test Technology recommended by WHO.